1/1
Export Ready

Gefitinib tablet

Sold by AYURSATVA PHARMA LLP · Raigad, Maharashtra, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HSN Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Global markets
Values shown are for AYURSATVA PHARMA LLP.
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

AYURSATVA PHARMA LLP is a verified supplier based in Raigad Maharashtra India.

Raigad Dispatch on request Verified seller
AYURSATVA PHARMA LLP logo

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

Established
Not shared
Employees
GST
27ACGFA6465R1ZM
IEC code
Not shared
Export markets
Global markets
GlobalLinker Member Since
Not shared
Turnover
On request
Incorporation Type
On request
Certifications & Awards
Product details

What are the specifications of this product?

Overview

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer.

Product Description

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer.

Description provided by AYURSATVA PHARMA LLP.

Specifications

Composition Each tablet contains 250 mg of gefitinib
Form Film-coated tablet
Shelf Life Typically 24 months from manufacturing date
Storage Instructions Store in a cool, dry place away from light and moisture
Packaging Details Available in strips of 10 tablets or bottles as per order size
Manufacturer Information available upon inquiry
Indications NSCLC with confirmed EGFR mutation
Contraindications Known hypersensitivity to gefitinib or excipients
Warnings Not recommended for patients without EGFR mutations; monitor for interstitial lung disease
Prescription Status Prescription only medication

Use cases

Category Pharmaceuticals > Oncology > Anti-Cancer Drugs > Targeted Therapy Drugs
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form Film-coated tablet

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Gefitinib tablet. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is Geftinat 250mg Tablet suitable for all NSCLC patients?
A: No, Geftinat 250mg Tablet is specifically indicated for NSCLC patients with confirmed EGFR mutations only.
Q: How should Geftinat 250mg Tablet be stored to maintain efficacy?
A: It should be stored in a cool, dry place away from direct light and moisture to preserve its potency and shelf life.
Q: Can Geftinat be prescribed without prior EGFR mutation testing?
A: No, it should only be prescribed after confirmation of EGFR mutation to ensure effective targeted therapy.
Q: What are the key safety concerns when using Geftinat 250mg Tablet?
A: Patients should be monitored for interstitial lung disease and hypersensitivity reactions during treatment with Geftinat.
Q: Is Geftinat 250mg Tablet available for bulk purchase for hospitals and oncology centers?
A: Yes, it is available in bulk packaging options tailored for institutional buyers such as hospitals and cancer treatment centers.
Question not answered? Ask sellers directly — typical response within 4 hours.
Gefitinib tablet
Gefitinib tablet
Price on request · MOQ 1Centimetre